Limited liver and bile duct surgery for bile duct cancer
Part of Cancer clinical trials.
This study tests a surgery that removes part of the liver and bile ducts in a specific way for bile duct cancer at the liver hilum. The goal is to see if this approach helps improve survival and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have bile duct cancer at the liver hilum (where the bile ducts meet) or strong suspicion of it.
- You are able to understand and cooperate with the study process.
- You can give written permission to take part in the study before any screening tests.
- Your cancer has not spread to other organs or distant lymph nodes.
- You have not already had surgery that was only for symptom relief.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients who had surgery for a specific type of bile duct cancer (hilar cholangiocarcinoma). It aims to see whether removing a nearby blood vessel during that surgery helps people live longer and have fewer complications after the operation.
This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.
This study tests giving chemo and radiation before a liver transplant for an unresectable bile duct cancer near the liver (hCCA). If your cancer can’t be removed with surgery right now, this approach aims to shrink and control it so transplant may become an option.
This trial tests a new combination of immunotherapy (tislelizumab), radiation, and chemotherapy before surgery for people with bile duct cancer that is hard to remove. The goal is to shrink the tumor enough to allow successful surgery.
This trial tests whether a living donor liver transplant can help people with a certain type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. It is for patients whose cancer has not spread and who have responded well to chemotherapy.
This trial combines proton beam therapy with a liver transplant to treat a specific type of bile duct cancer (hilar cholangiocarcinoma). It aims to improve outcomes by using radiation before surgery to help make the transplant more successful.
Hear when a new Cholangiocarcinoma, Hilar trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.